Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)

Author： Rathore Ritesh   Birnbaum Ariel   Rathore Bharti   DiPetrillo Thomas   Kennedy Teresa   Ready Neal  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.66, Iss.6, 2010-11, pp. : 1013-1017

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

By Samlowski Wolfram E.   Moon James   Kuebler J. Philip   Nichols Craig R.   Gandara David R.   Ozer Howard   Williamson Stephen K.   Atkins James N.   Schuller David E.   Ensley John F.  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers

By Zhang Jingsong   Lee Julia   Urba Susan   Foster Jared   Worden Francis  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 910-916

Informa Healthcare

Access to resources Recommend Favorite

Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: A Hellenic Cooperative Oncology Group (HeCOG) phase II study

By Makatsoris Thomas   Papakostas Pavlos   Kalofonos Haralabos   Xanthakis Ioannis   Tsavdaridis Dimitrios   Aravantinos Gerasimos   Gogas Helen   Klouvas George   Kosmidis Paris   Pectasides Dimitrios   Fountzilas George  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 301-307

Humana Press, Inc

Access to resources Recommend Favorite

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

By Rein D.T.   Kurbacher C.M.   Breidenbach M.   Schöndorf T.   Schmidt T.   König E.       Mallmann P.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 98-103

Academic Press

Access to resources Recommend Favorite

Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors

By Masters Gregory   Brockstein Bruce   Mani Sridhar   Ratain Mark  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 7-12

Humana Press, Inc

Access to resources Recommend Favorite